Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
AIQUY US​

L Air Liquide Sa /FI Unsponsored ADR(AIQUY US)

$39.01-0.060.15%Ext:$39.02+0.010.02%(Market Closed · 20:00:00 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

L Air Liquide Sa /FI Unsponsored ADR — Company Profile

L'Air Liquide S.A., established in Paris, France, in 1902, is a worldwide leader in providing essential industrial and medical gases, cutting-edge technologies, and specialized services. Its operations extend across Europe, the Americas, Asia Pacific, the Middle East, and Africa. Through its Gas & Services division, the company delivers fundamental industrial gases, including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, to heavy industries such as metallurgy, chemical processing, refining, and energy. This segment also provides a broad array of gases, application-specific equipment, and associated support to diverse sectors like materials and energy, automotive, manufacturing, food and pharmaceuticals, technology and research, as well as independent businesses and retailers. In the healthcare domain, L'Air Liquide furnishes medical gases, hygiene products, vital equipment, and care services to hospitals and for patients receiving home care. Additionally, it manufactures and distributes specialized healthcare ingredients essential for the cosmetics, pharmaceutical, and vaccine markets. Crucially, it supplies gases, materials, and services integral to the production of semiconductors, flat panel displays, and photovoltaic cells. The Engineering & Construction arm focuses on the design, development, and construction of industrial gas production facilities, both for internal use and for external clients. It further specializes in designing and building plants tailored for various energy sectors, encompassing traditional, renewable, and alternative sources. Finally, the Global Markets & Technologies segment is dedicated to developing and deploying advanced technological solutions, including specialized molecules, equipment, and services. These innovations primarily support the global energy transition, with a strong focus on sustainable transport, energy generation, and waste valorization. This segment also engages in deep technological ventures, aiding endeavors in space exploration, aerospace, and large-scale scientific initiatives. Committed to fostering clean mobility, it invests in biomethane production facilities and establishes distribution networks for natural bio-gas for vehicles and hydrogen for transport. Furthermore, it manages biomethane production specifically for the maritime industry and supplies gases to offshore oil and gas platforms, wind turbines, and for cryogenic shipping operations.

Sector
Industrials
Industry
Professional Services
Exchange
UU
CEO
Francois Jackow
Headquarters
Paris, I0, FR
IPO Date
Jun 22, 2007
Employees
65,168
Website
www.airliquide.com

Financials & Metrics

FinancialsChartingShort InterestEmployees

Key Metrics

Price
$38.12
Market Cap
$24.15B
Revenue (TTM)
$25.88B
Net Income (TTM)
$3.38B
EPS (TTM)
1.17
P/E (TTM)
0.00
P/B (TTM)
0.92
Dividend Yield
2.14%
ROE (TTM)
12.90%
ROA (TTM)
6.51%
Operating Margin
20.72%
Beta
0.20

Dividends

Last Dividend
$0.86
Last Yield
0.02%

Summary

L'Air Liquide S.A., established in Paris, France, in 1902, is a worldwide leader in providing essential industrial and medical gases, cutting-edge technologies, and specialized services. Its operations extend across Europe, the Americas, Asia Pacific, the Middle East, and Africa. Through its Gas & Services division, the company delivers fundamental industrial gases, including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, to heavy industries such as metallurgy, chemical processing, refining, and energy. This segment also provides a broad array of gases, application-specific equipment, and associated support to diverse sectors like materials and energy, automotive, manufacturing, food and pharmaceuticals, technology and research, as well as independent businesses and retailers. In the healthcare domain, L'Air Liquide furnishes medical gases, hygiene products, vital equipment, and care services to hospitals and for patients receiving home care. Additionally, it manufactures and distributes specialized healthcare ingredients essential for the cosmetics, pharmaceutical, and vaccine markets. Crucially, it supplies gases, materials, and services integral to the production of semiconductors, flat panel displays, and photovoltaic cells. The Engineering & Construction arm focuses on the design, development, and construction of industrial gas production facilities, both for internal use and for external clients. It further specializes in designing and building plants tailored for various energy sectors, encompassing traditional, renewable, and alternative sources. Finally, the Global Markets & Technologies segment is dedicated to developing and deploying advanced technological solutions, including specialized molecules, equipment, and services. These innovations primarily support the global energy transition, with a strong focus on sustainable transport, energy generation, and waste valorization. This segment also engages in deep technological ventures, aiding endeavors in space exploration, aerospace, and large-scale scientific initiatives. Committed to fostering clean mobility, it invests in biomethane production facilities and establishes distribution networks for natural bio-gas for vehicles and hydrogen for transport. Furthermore, it manages biomethane production specifically for the maritime industry and supplies gases to offshore oil and gas platforms, wind turbines, and for cryogenic shipping operations.

Website
www.airliquide.com
Location
Paris, I0, FR
Phone33 1 40 62 55 55
Employees65,168
CEOFrancois Jackow
Sector
Industrials
Industry
Professional Services
IPO DateJun 22, 2007

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(44)

Expand
  • F-6EFEffective registration statement (depository shares)26 Sep 2024
  • F-6EFEffective registration statement (depository shares)26 Feb 2024
  • F-6EFEffective registration statement (depository shares)25 Nov 2019
  • F-6 POSPost-effective amendment (depository shares)29 Sep 2017
  • F-6EFEffective registration statement (depository shares)8 Jun 2011
  • SUPPLAUTO-GENERATED PAPER DOCUMENT6 Oct 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT11 Aug 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT23 Jul 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT25 Jun 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT19 May 2008
  • ARSAUTO-GENERATED PAPER DOCUMENT24 Apr 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT16 Apr 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT4 Mar 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT4 Feb 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT15 Jan 2008
  • SUPPLAUTO-GENERATED PAPER DOCUMENT3 Dec 2007
  • EFFECTNotice of effectiveness29 Nov 2007
  • SUPPLAUTO-GENERATED PAPER DOCUMENT15 Nov 2007
  • F-6Registration statement (depository shares)15 Nov 2007
  • SUPPLAUTO-GENERATED PAPER DOCUMENT16 Oct 2007

News

  • L'Air Liquide S.A. (AIQUY) Analyst/Investor Day Transcript8 Oct
  • Air Liquide Targets Sales, Margin Growth Under 2030 Plan5 Oct
  • AVNT or AIQUY: Which Is the Better Value Stock Right Now?25 Sep
  • Air Liquide (OTCMKTS:AIQUY) Shares Pass Below Fifty Day Moving Average – Should You Sell?11 Sep
  • AVNT vs. AIQUY: Which Stock Is the Better Value Option?9 Sep
  • Air Liquide: Elliott Adds Capital Return Upside To The Margin Expansion Story9 Sep
  • Air Liquide rises as Elliott reportedly builds stake, pushes for higher margins1 Sep
  • AVNT or AIQUY: Which Is the Better Value Stock Right Now?24 Aug
  • AVNT or AIQUY: Which Is the Better Value Stock Right Now?6 Aug
  • L'Air Liquide S.A. (AIQUY) Q2 2026 Earnings Call Transcript28 Jul
  • Quality Isn't Worth Anything, And Air Liquide Proves It28 Jul
  • Air Liquide Backs Guidance After Revenue, Margin Improvements28 Jul
  • Air Liquide confirms margin outlook as first-half profit meets expectations28 Jul

Mentions in Filings

  • ***Independent Director*** - ***Hoan S. Lee, Ph.D. –*** Dr. Lee is expected to serve as a director of PubCo following the Business Combination. Dr. Lee has extensive experience in quantitative finance, investment management, and AI infrastructure. Since 2022, he has served as Chief Executive Officer, Chief Financial Officer, and Director of Exascale Labs Inc, a next-generation AI infrastructure provider. Since 2019, he has served as Founder and M …
    CADV Ventures S.A.L Air Liquide Sa /FI Unsponsored ADR·S-4/A - Registration statement (business combination, amendment)·Q4 26·15 Oct
  • ***Independent Director*** - ***Hoan S. Lee, Ph.D. –*** Dr. Lee is expected to serve as a director of PubCo following the Business Combination. Dr. Lee has extensive experience in quantitative finance, investment management, and AI infrastructure. Since 2022, he has served as Chief Executive Officer, Chief Financial Officer, and Director of Exascale Labs Inc, a next-generation AI infrastructure provider. Since 2019, he has served as Founder and M …
    CADV Ventures S.A.L Air Liquide Sa /FI Unsponsored ADR·S-4/A - Registration statement (business combination, amendment)·Q3 26·17 Sep
  • ***Independent Director*** - ***Hoan S. Lee, Ph.D. –*** Dr. Lee is expected to serve as a director of PubCo following the Business Combination. Dr. Lee has extensive experience in quantitative finance, investment management, and AI infrastructure. Since 2022, he has served as Chief Executive Officer, Chief Financial Officer, and Director of Exascale Labs Inc, a next-generation AI infrastructure provider. Since 2019, he has served as Founder and M …
    CADV Ventures S.A.L Air Liquide Sa /FI Unsponsored ADR·S-4 - Registration statement (business combination)·Q3 26·27 Aug
  • … und or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public. Item C.1. Identification of investment. a. Name of issuer (if any). <strong>L'AIR LIQUIDE</strong> SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE SA b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series. 969500MMPQV …
    Dimensional ETF TrustL Air Liquide Sa /FI Unsponsored ADR·NPORT-P - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • ***Independent Director*** - ***Hoan S. Lee, Ph.D. –*** Dr. Lee is expected to serve as a director of PubCo following the Business Combination. Dr. Lee has extensive experience in quantitative finance, investment management, and AI infrastructure. Since 2022, he has served as Chief Executive Officer, Chief Financial Officer, and Director of Exascale Labs Inc, a next-generation AI infrastructure provider. Since 2019, he has served as Founder and M …
    CADV Ventures S.A.L Air Liquide Sa /FI Unsponsored ADR·DRS/A - Draft registration statement (amendment)·Q3 26·12 Aug
  • ***Independent Director*** - ***Hoan S. Lee, Ph.D. –*** Dr. Lee is expected to serve as a director of PubCo following the Business Combination. Dr. Lee has extensive experience in quantitative finance, investment management, and AI infrastructure. Since 2022, he has served as Chief Executive Officer, Chief Financial Officer, and Director of Exascale Labs Inc, a next-generation AI infrastructure provider. Since 2019, he has served as Founder and M …
    CADV Ventures S.A.L Air Liquide Sa /FI Unsponsored ADR·DRS/A - Draft registration statement (amendment)·Q3 26·28 Jul

Key Stats

Trading

Px/Chg 1D$38.12 / +2.03%
Prev Close$39.53
% of 52Wk H90.12%
Avg Volume218.92K
Beta0.20
Mkt Cap24.15B
FD Mkt Cap25.36B

Float

Shrs Out/Float633.51M / 633.51M
Short Float0.00%
Days to Cover1.00
Stock Repurchased$3.84M

Current Valuation

EV34.52B
EV/EBITDA0.00
EV/Sales0.00
P/B0.92
P/S0.00
FCF Yield6.40%
ROE12.90%
ROA6.51%
Current Ratio1.14

Dividend

Cash$0.86
Yield2.14%
Yield (TTM)2.14%

Estimates

P/E0.00
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgJun '22Jun '23Jun '24Jun '25Oct '26
PRICE-BASED RATIOS
Price / Earnings25.4322.9227.7829.3832.8214.23
Price / Sales2.842.532.563.284.011.85
Price / Book Value2.932.753.233.724.040.93
Price / Free Cash Flow28.6324.0233.1131.5138.8015.69
ENTERPRISE VALUE METRICS
Enterprise Value83,229.471,131.489,016.4101,561.2119,812.234,625.8
Enterprise Value / Sales3.353.052.973.684.432.64
Enterprise Value / EBITDA12.9511.6513.0715.1316.438.46
Enterprise Value / EBIT19.7418.0819.3224.0225.0412.26

Financials

Full Financials
Millions EUR5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue2.6%23,334.829,934.027,607.627,057.825,876.9
Gross Income-9.7%13,946.116,121.016,460.817,049.69,256.7
EBITDA6.4%6,107.76,813.26,710.47,290.77,823.6
EBIT8%3,935.24,608.34,228.44,785.65,361.3
Net Income7.1%2,572.22,758.83,078.03,306.13,379.1
EPS (Diluted)6.8%0.900.961.071.141.17
BALANCE SHEET
Cash & ST Inv15.2%2,246.61,911.41,624.71,915.33,960.3
Total Assets2.6%46,783.149,518.048,332.451,867.551,891.3
Total Liabilities26.3%24,694.624,840.523,289.324,246.224,955.6
Total Shareholder Equity5.1%21,462.323,736.424,321.526,860.026,202.7
CASH FLOW
Net Operating Cash Flow2.3%5,570.75,810.16,263.06,322.26,104.0
Cap Ex6.1%-2,916.8-3,273.0-3,393.4-3,525.1-3,691.7
Free Cash Flow-43.3%2,454.52,314.82,869.62,797.12,412.3

Enterprise Value Bridge

Millions EUR23 Oct '26
Price (As of 23 Oct '26)39.03
Basic Shares633.51
Market Cap24,726.1
Diluted Shares2,883.87
Fully Diluted Shares Outstanding2,883.87
Fully Diluted Market Cap112,557.4
+Consolidated Debt13,595.9
−In-the-Money Convertible Debt—
+Capital Leases1,259.0
+Operating Leases—
−Cash & Equivalents-3,960.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest733.0
+Pension Liabilities—
Enterprise Value35,094.6

Related companies

Iqvia Holdings Inc.

IQV US

Wanhua Chemical Group Co., Ltd.

600309 CG

Novozymes As/fi

NVZMY US

DSM-Firmenich AG/ADR

DSFIR NA

EMS-Chemie Holding AG/ADR

EMSHF US

Incyte Corp

INCY US

Grace Fabric Technology Co.,Ltd.

603256 CG

Medpace Holdings, Inc.

MEDP US

Nippon Paint Holdings Co., Ltd.

NPCPF US

Covestro AG/ADR

COVTY US

Symrise AG

SYIEY US

Charles River Laboratories International, Inc.

CRL US